Articles On NeuroScientific Biopharmaceuticals (ASX:NSB)
| Title | Source | Codes | Date |
|---|---|---|---|
|
This year’s Biotech Lunch in WA is all about building a sustainable ecosystem in the Perth market
The WA investment community will turn its attention to healthcare next Thursday, when the annual Biotech Lunch takes place in Perth. Hosted by industry entrepreneur Brian Leedman, the luncheon will provide a forum for brokers and investors... |
Stockhead | NSB | 5 years ago |
|
NeuroScientific reveals positive results from pre-clinical glaucoma study
Drug developer NeuroScientific Biopharmaceuticals (ASX: NSB) has revealed the first pre-clinical results of an ophthalmology program that has demonstrated the potential for its lead drug candidate EmtinB to become a “revolutionary” treatmen... |
SmallCaps | NSB | 5 years ago |
|
10 at 10: These ASX stocks are on the dancefloor this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | NSB | 5 years ago |
|
Rise & Shine: What you need to know before the ASX opens
On Stockhead today: Aussie small caps trying to tackle the opioid crisis, which car manufacturers will survive the EV revolution, Barry FitzGerald looks at upcoming juniors, and how South Australian small caps are putting themselves back on... |
Stockhead | NSB | 5 years ago |
|
Rise & Shine: What you need to know before the ASX opens
On Stockhead today: our report on the 100 best performing stocks for the year, how four directors put in $5.1 million to make a quick $1.4 million, what are the hottest stocks on the ASX right now and Dr Boreham’s prognosis of Suda. But fir... |
Stockhead | NSB | 5 years ago |
|
In 2019, 23 stocks have jumped over 100pc in one day. Why and where are they now?
At Stockhead we are as amazed as our readers when stocks rise by over 100 per cent in a day. But its a more common occurrence than we thought. There have been 23 stocks that have achieved that feat. The three most common reasons are success... |
Stockhead | NSB | 5 years ago |
|
Why this ASX microcap skyrocketed 190% on Tuesday
The Neuroscientific Biopharmaceuticals Ltd (ASX: NSB) share price skyrocketed 190% on Tuesday after news that the company’s flagship drug EmtinB was part of a successful study into the treatment of Alzheimer’s disease as well as a range of... |
Motley Fool | NSB | 5 years ago |
|
Neuroscientific Biopharmaceuticals Share Price Soars after Drug Breakthrough
The share price of Neuroscientific Biopharmaceuticals Ltd [ASX:NSB] is up a massive 175.86% trading at 40 cents following the end of its trading halt - the company announced today ‘breakthrough’ results for its Alzheimer’s drug and investor... |
MoneyMorning | NSB | 5 years ago |
|
NeuroScientific publishes positive results in fight against Alzheimer’s
Alzheimer’s treatment could be set for a significant boost following the publication of what NeuroScientific Biopharmaceuticals (ASX: NSB) calls a “breakthrough study” into its lead drug candidate EmtinB using rat tissue. Contract researche... |
SmallCaps | NSB | 5 years ago |
|
Top 10 at 10: These ASX stocks are up and about this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | NSB | 5 years ago |